Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "There is only one stock in pharma that is Ajanta Pharma where after a big decline a bullish pattern is emerging and it is trying to breakout on the upside. Most of the pharma companies, at least the large cap pharma are in sustained distribution and decline. I don't think we should be buying them at all."At 15:18 hrs Ajanta Pharma was quoting at Rs 1,337.60, down Rs 57.10, or 4.09 percent. It has touched an intraday high of Rs 1,404.00 and an intraday low of Rs 1,311.75.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!